TY - JOUR
T1 - Perioperative outcomes of patients undergoing urological elective surgery during the covid-19 pandemic
T2 - A national overview across 28 italian institutions
AU - Minervini, Andrea
AU - Di Maida, Fabrizio
AU - Mari, Andrea
AU - Porreca, Angelo
AU - Rocco, Bernardo
AU - Celia, Antonio
AU - Bove, Pierluigi
AU - Umari, Paolo
AU - Volpe, Alessandro
AU - Galfano, Antonio
AU - Pastore, Antonio Luigi
AU - Annino, Filippo
AU - Parma, Paolo
AU - Greco, Francesco
AU - Nucciotti, Roberto
AU - Schiavina, Riccardo
AU - Esposito, Fabio
AU - Romagnoli, Daniele
AU - Leonardo, Costantino
AU - Falabella, Roberto
AU - Gallo, Fabrizio
AU - Amenta, Michele
AU - Sciorio, Carmine
AU - Verze, Paolo
AU - Tafuri, Alessandro
AU - Pucci, Luigi
AU - Varca, Virginia
AU - Zaramella, Stefano
AU - Pagliarulo, Vincenzo
AU - Bozzini, Giorgio
AU - Ceruti, Carlo
AU - Falsaperla, Mario
AU - Cafarelli, Angelo
AU - Antonelli, Alessandro
N1 - Publisher Copyright:
© 2021, Polish Urological Association. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Introduction The aim of this study was to assess the safety of elective urological surgery performed during the pandemic by estimating the prevalence of COVID-19-like symptoms in the postoperative period and its correlation with perioperative and clinical factors. Material and methods In this multicenter, observational study we recorded clinical, surgical and postoperative data of consecutive patients undergoing elective urological surgery in 28 different institutions across Italy during initial stage of the COVID-19 pandemic (between February 24 and March 30, 2020, inclusive). Results A total of 1943 patients were enrolled. In 12%, 7.1%, 21.3%, 56.7% and 2.6% of cases an open, laparoscopic, robotic, endoscopic or percutaneous surgical approach was performed, respectively. Overall, 166 (8.5%) postoperative complications were registered, 77 (3.9%) surgical and 89 (4.6%) medical. Twenty-eight (1.4%) patients were readmitted to hospital after discharge and 13 (0.7%) died. In the 30 days following discharge, fever and respiratory symptoms were recorded in 101 (5.2%) and 60 (3.1%) patients. At multivariable analysis, not performing nasopharyngeal swab at hospital admission (HR 2.3; CI 95% 1.01–5.19; p = 0.04) was independently associated with risk of developing postoperative medical complications. Number of patients in the facility was confirmed as an independent predictor of experiencing postoperative respiratory symptoms (p = 0.047, HR:1.12; CI95% 1.00–1.05), while COVID-19-free type of hospitalization facility was a strong independent protective factor (p = 0.02, HR:0.23, CI95% 0.07–0.79). Conclusions Performing elective surgery during the COVID-19 pandemic does not seem to affect periop-erative outcomes as long as proper preventive measures are adopted, including nasopharyngeal swab before hospital admission and hospitalization in dedicated COVID-19-free facilities.
AB - Introduction The aim of this study was to assess the safety of elective urological surgery performed during the pandemic by estimating the prevalence of COVID-19-like symptoms in the postoperative period and its correlation with perioperative and clinical factors. Material and methods In this multicenter, observational study we recorded clinical, surgical and postoperative data of consecutive patients undergoing elective urological surgery in 28 different institutions across Italy during initial stage of the COVID-19 pandemic (between February 24 and March 30, 2020, inclusive). Results A total of 1943 patients were enrolled. In 12%, 7.1%, 21.3%, 56.7% and 2.6% of cases an open, laparoscopic, robotic, endoscopic or percutaneous surgical approach was performed, respectively. Overall, 166 (8.5%) postoperative complications were registered, 77 (3.9%) surgical and 89 (4.6%) medical. Twenty-eight (1.4%) patients were readmitted to hospital after discharge and 13 (0.7%) died. In the 30 days following discharge, fever and respiratory symptoms were recorded in 101 (5.2%) and 60 (3.1%) patients. At multivariable analysis, not performing nasopharyngeal swab at hospital admission (HR 2.3; CI 95% 1.01–5.19; p = 0.04) was independently associated with risk of developing postoperative medical complications. Number of patients in the facility was confirmed as an independent predictor of experiencing postoperative respiratory symptoms (p = 0.047, HR:1.12; CI95% 1.00–1.05), while COVID-19-free type of hospitalization facility was a strong independent protective factor (p = 0.02, HR:0.23, CI95% 0.07–0.79). Conclusions Performing elective surgery during the COVID-19 pandemic does not seem to affect periop-erative outcomes as long as proper preventive measures are adopted, including nasopharyngeal swab before hospital admission and hospitalization in dedicated COVID-19-free facilities.
KW - COVID-19
KW - Coronavirus
KW - Infection
KW - Outcome
KW - Surgery
KW - Urology
UR - http://www.scopus.com/inward/record.url?scp=85110059932&partnerID=8YFLogxK
U2 - 10.5173/ceju.2021.0374
DO - 10.5173/ceju.2021.0374
M3 - Article
SN - 2080-4806
VL - 74
SP - 259
EP - 268
JO - Central European Journal of Urology
JF - Central European Journal of Urology
IS - 2
ER -